跳至主要内容
临床试验/NCT00939393
NCT00939393已完成不适用

ESS Performed in Operating Room Versus Clinician's Office

Integra LifeSciences Corporation2 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2008年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
72
试验地点
2
主要终点
Mean Intra-patient Change in SNOT-20 Score at 24 Weeks Post-procedure Compared to Baseline

研究概览

简要总结

Endoscopic sinus surgery will be performed either in the physician's office or in the operating room (OR). Patients treated in the physician's office will have endoscopic sinus surgery performed with balloon sinuplasty devices. Patients treated in the OR will have endoscopic sinus surgery performed with or without balloon sinuplasty devices.

详细描述

In this study, endoscopic sinus surgery will be performed either in the physician's office or in the operating room (OR). Patients treated in the physician's office will have endoscopic sinus surgery performed with the balloon sinuplasty devices. Patients treated in the OR will have endoscopic sinus surgery performed with or without balloon sinuplasty devices. Both primary treatment of sinusitis as well as revision of previously treated sinuses will be allowed. Resource absorption will be evaluated for both venues.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years and greater
  • Both male and female patients eligible
  • Diagnosis of chronic sinusitis that is not responsive to medical management (> 12 weeks of symptoms and failed at least 3 to 6 weeks of appropriate antibiotic therapy as evidenced by presence of disease on CT scan)
  • Planned endoscopic sinus surgery (recommended by investigator, consented to by patient)

排除标准

  • Cystic fibrosis
  • Samter's Triad (Aspirin sensitivity, Asthma, Sinonasal polyposis)
  • Sinonasal tumors or obstructive lesions
  • History of facial trauma that distorts sinus anatomy and precludes access to the sinus ostium
  • Ciliary dysfunction
  • Pregnant females

结局指标

主要结局

Mean Intra-patient Change in SNOT-20 Score at 24 Weeks Post-procedure Compared to Baseline

时间窗: 24 weeks

The 20 question Sino-Nasal Outcome Test (SNOT-20) will be used to evaluate sinus symptoms and sinus-symptom related quality of life (QOL) at baseline, 1 week, 4 weeks, 24 weeks and 52 weeks post-procedure. The change in SNOT-20 score at each post-procedure time point will be evaluated compared to baseline SNOT-20 score. Each of the 20 questions in the SNOT-20 survey is scored on a scale of 0 to 5, where '0' represents 'no problem' and '5' represents 'problem as bad as it can be'. The 20 questions are expressed as a mean of the scores. Therefore, the minimum mean score is zero and the maximum mean score is 5.

次要结局

  • Mean Number of Debridements Per Participant (IO Only)(52 weeks)
  • Mean Intra-patient Change in SNOT-20 Score at 52 Weeks Post-procedure Compared to Baseline(52 weeks)
  • Proportion of Participants With Post-operative Sinus Infections(52 weeks)
  • Mean Intra-patient Change in SNOT-20 Score at 1 Week Post-procedure Compared to Baseline(1 week)
  • Proportion of Participants Reporting No Pain or Pain of Low Intensity (IO Only)(Day 0)
  • Mean Intra-patient Change in Lund-MacKay CT Score [24 Weeks](24 weeks)
  • Proportion of Participants Rating Procedure as Tolerable (IO Only)(Day 0)
  • Proportion of Participants With Revisions (IO Only)(52 weeks)
  • Mean Intra-patient Change in SNOT-20 Score at 4 Weeks Post-procedure Compared to Baseline(4 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验